Evidence map›Paper›PMID 42083552›Full record

ReviewOncoTargets and therapy2026

Advances in the Treatment of Breast Cancer at Different Stages of Pregnancy.

Jiajin Lv, Xu Lin

Abstract readReview
In one paragraph

Review in OncoTargets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jiajin LvBasic Medical College, Hebei North University, Zhangjiakou, Hebei, People's Republic of China.
Xu LinDepartment of Morphology Laboratory, Hebei North University, Zhangjiakou, Hebei, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregnancy-associated breast cancer (PABC) refers to newly occurring breast cancer from the beginning of pregnancy to within one year after delivery. In recent years, with changes in societal attitudes toward fertility, the number of women marrying and giving birth at older ages has steadily increased. The delay in the age of childbearing has gradually increased the risk of women being exposed to breast cancer during pregnancy, and thus the incidence of PABC has been on the rise. The treatment of PABC is challenging. The treatment plan should not only control the tumor progression of the patient but also ensure the healthy development of the fetus. Therefore, it is very important to formulate an individualized diagnosis and treatment plan. Thus, this article explores the diagnosis and treatment methods of PABC to respectively expound the feasibility and safety of the relevant diagnosis and treatment means in the first, second and third trimesters of pregnancy.

Indexed as

breast cancer during pregnancychemotherapysurgerytargeted therapy

Identifiers

PMID42083552
PMCPMC13135752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.